Literature DB >> 8985214

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.

M J Mayaux1, E Dussaix, J Isopet, C Rekacewicz, L Mandelbrot, N Ciraru-Vigneron, M C Allemon, V Chambrin, C Katlama, J F Delfraissy, J Puel.   

Abstract

Virus load in pregnancy and its relation to mother-to-child human immunodeficiency virus (HIV) transmission were studied prospectively. From 1989 to 1994, 320 HIV-infected women from 18 centers had plasma samples stored. Among women not receiving antiretroviral therapy, the polymerase chain reaction RNA level was 3.6 log at delivery, and 15% of women had levels below the detection limit. There was no variation during pregnancy. Women born in sub-Saharan Africa had lower RNA levels, although their CD4 cell distribution did not differ from that in other women. Among 236 evaluable children, 19% +/- 5% were infected. Transmission occurred in 12% of cases (confidence interval, 5%-22%) with <1000 copies/mL versus 29% +/- 10% of those with >10,000 copies/mL (P < .02). Maternal virus load appears strongly related to HIV transmission to the child.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985214     DOI: 10.1093/infdis/175.1.172

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; M D Miller; M L Marthas; N A Margot; P J Dailey; D R Canfield; R P Tarara; J M Cherrington; N L Aguirre; N Bischofberger; N C Pedersen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Human immunodeficiency virus infection in pregnancy.

Authors:  Y Arikan; D R Burdge
Journal:  Can J Infect Dis       Date:  1998-09

3.  Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Authors:  Risa M Hoffman; Vivian Black; Karl Technau; Karin Joan van der Merwe; Judith Currier; Ashraf Coovadia; Matthew Chersich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

Review 4.  British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998).

Authors:  G P Taylor; E G Lyall; D Mercey; R Smith; T Chester; M L Newell; G Tudor-Williams
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

5.  The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.

Authors:  Woottichai Khamduang; Gonzague Jourdain; Wasna Sirirungsi; Prapaisri Layangool; Suparat Kanjanavanit; Pornsuda Krittigamas; Karin Pagdi; Rosalin Somsamai; Surat Sirinontakan; Temsiri Hinjiranandana; Wanna Ardonk; Suchat Hongsiriwon; Sirisak Nanta; Thitiporn Borkird; Marc Lallemant; Kenneth McIntosh; Nicole Ngo-Giang-Huong
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 6.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

7.  Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.

Authors:  Charmaine P Mutucumarana; Joshua Eudailey; Erin P McGuire; Nathan Vandergrift; Gerald Tegha; Charles Chasela; Sascha Ellington; Charles van der Horst; Athena P Kourtis; Sallie R Permar; Genevieve G Fouda
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

Review 8.  Treatment of HIV infection in pregnant women: antiretroviral management options.

Authors:  Mona R Loutfy; Sharon L Walmsley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.

Authors:  Kerina Duri; Felicity Z Gumbo; Knut I Kristiansen; Nyaradzi E Kurewa; Munyaradzi P Mapingure; Simbarashe Rusakaniko; Mike Z Chirenje; Fredrik Muller; Babill Stray-Pedersen
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

10.  HIV-prevention science at a crossroads: advances in reducing sexual risk.

Authors:  Sten H Vermund; Katherine L Allen; Quarraisha Abdool Karim
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.